DOXGX | DVRUX | DOXGX / DVRUX | |
Total Expense Ratio | 0.41 | 0.50 | 82% |
Annual Report Gross Expense Ratio | 0.46 | 0.86 | 53% |
Fund Existence | 3 years | 5 years | - |
Gain YTD | 3.684 | 5.953 | 62% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 114B | 259M | 44,015% |
Annual Yield % from dividends | 1.49 | 1.35 | 110% |
Returns for 1 year | 6.03 | 12.52 | 48% |
Returns for 3 years | 28.44 | 50.98 | 56% |
Returns for 5 years | N/A | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTCX | 20.46 | -0.13 | -0.63% |
Fidelity Advisor Biotechnology C | |||
AZNCX | 9.52 | -0.06 | -0.63% |
Virtus Income & Growth C | |||
CAEIX | 11.87 | -0.12 | -1.00% |
Calvert Global Energy Solutions I | |||
MCGCX | 19.20 | -0.23 | -1.18% |
BlackRock Advantage Global Investor C | |||
SFPAX | 10.34 | -0.21 | -1.99% |
Saratoga Financial Service A |